Boğaziçi CT3 (Center for Targeted Therapy Technologies of Boğaziçi University) is a prominent research center within Boğaziçi University (Istanbul, Türkiye), focusing on innovative and high-impact research in life sciences and technologies.
The center leverages Boğaziçi University's strengths in natural and applied sciences to drive technological advancements, not only in the rapidly advancing fields of medical biotechnology, but also within a novel set of “smart” in vivo biomedical devices.
It fosters active collaborations between academia, industry, and healthcare sector with its recently updated sharp focus on targeted therapy technologies.
Established within one of nation’s leading universities, Boğaziçi University’s CT3 supports multidisciplinary research and is the national trailblazer when it comes to successful technology transfer, academic spin-off and commercialization activities from biomedical and biotechnological academic innovations.